Categories: Wire Stories

UMC Files Form 20-F for 2019 with US Securities and Exchange Commission

TAIPEI, Taiwan–(BUSINESS WIRE)–United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today filed its 2019 annual report on Form 20-F with the US Securities and Exchange Commission. The report is available at http://www.umc.com/english/investors/Reports/2010-present_report.asp.

About UMC

UMC (NYSE: UMC, TWSE: 2303) is a leading global semiconductor foundry. The company provides high quality IC production with a focus on both logic and specialty technologies to serve every major sector of the electronics industry. UMC’s comprehensive technology and manufacturing solutions include logic/RF, embedded high voltage, embedded flash, RFSOI/BCD on 8″ & 12″ wafers and IATF-16949 automotive manufacturing certification for all its manufacturing facilities. UMC operates 12 fabs that are strategically located throughout Asia with a maximum capacity of more than 750,000 8-inch equivalent wafers per month. The company employs approximately 19,000 people worldwide, with offices in Taiwan, China, United States, Europe, Japan, Korea and Singapore. For more information, please visit: http://www.umc.com.

Note from UMC Concerning Forward-Looking Statements

Some of the statements in the foregoing announcement are forward-looking within the meaning of the U.S. Federal Securities laws, including statements about introduction of new services and technologies, future outsourcing, competition, wafer capacity, business relationships and market conditions. Investors are cautioned that actual events and results could differ materially from these statements as a result of a variety of factors, including conditions in the overall semiconductor market and economy; acceptance and demand for products from UMC; and technological and development risks. Further information regarding these and other risks is included in UMC’s filings with the U.S. Securities and Exchange Commission. UMC does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

Contacts

Michael Lin / David Wong

UMC, Investor Relations
Tel. + 886-2-2658-9168, ext. 16900

jinhong_lin@umc.com
david_wong@umc.com

Alex

Recent Posts

Getting Ready: LUX Helps Female Ex-Offenders Reintegrate Back to Society

LUX Launches ‘Getting Ready’ Campaign to Inspire Ex-offenders to Re-embrace Beauty and Re-enter Society with…

30 mins ago

PROTEINA Initiates Global Clinical Validation Project with Emory University School of Medicine, USA

SEOUL, South Korea--(BUSINESS WIRE)--#AcuteMyeloidLeukemia--PROTEINA announced today that it has held a kickoff meeting with Professor…

59 mins ago

Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040 Conformal Coating System

Recognized at the Productronica China tradeshow, the SL-1040 elevates coating performance with improved yield and…

3 hours ago

Hong Kong Ups the Game with New Incentive Playbook

Largest Celebration Ever with Over 110 Agents from Eight Markets to Experience Ultimate Hong Kong…

3 hours ago

DTEN’s Next Generation Video Conferencing and Collaboration Device for Zoom and Microsoft Teams, Now available in South Korea

DTEN’s Flagship D7X All-in-One Solution is Now KC and KCC Certified in South Korea, Delivering…

4 hours ago

AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)

SEONGNAM-SI, South Korea--(BUSINESS WIRE)--AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA)…

5 hours ago